Onconetix, Inc. Cash and Restricted Cash
Onconetix, Inc. (ONCO) had Cash and Restricted Cash of $5.94 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Cash
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2026-08-13
- 2026-06-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $5.94M.
- 2026-03-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $3.72M.
- 2025-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $5.22M.
- 2025-09-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $836.56K.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
|---|---|
| 2026-06-30 | $5.94M 10-Q · filed 2026-08-13 |
| 2026-03-31 | $3.72M 10-Q · filed 2026-05-13 |
| 2025-12-31 | $5.22M 10-Q · filed 2026-08-13 |
| 2025-09-30 | $836.56K 10-Q · filed 2025-11-13 |
| 2025-06-30 | $283.51K 10-Q · filed 2026-08-13 |
| 2025-03-31 | $1.58M 10-Q · filed 2026-05-13 |
| 2024-12-31 | $646.50K 10-Q · filed 2026-08-13 |
| 2024-09-30 | $341.50K 10-Q · filed 2025-11-13 |
| 2024-06-30 | $930.54K 10-Q · filed 2025-08-14 |
| 2024-03-31 | $4.46M 10-Q · filed 2025-06-12 |
| 2023-12-31 | $4.55M 10-K · filed 2026-03-13 |
| 2023-09-30 | $7.65M 10-Q · filed 2024-12-10 |
| 2023-06-30 | $9.22M 10-Q · filed 2024-08-29 |
| 2023-03-31 | $21.26M 10-Q · filed 2024-05-20 |
| 2022-12-31 | $25.75M 10-K · filed 2025-06-02 |
| 2022-09-30 | $29.14M 10-Q · filed 2023-11-17 |
| 2022-06-30 | $22.24M 10-Q · filed 2023-10-20 |
| 2022-03-31 | $18.61M 10-Q · filed 2023-05-12 |
| 2021-12-31 | $1.93M 10-K · filed 2024-04-11 |
| 2021-09-30 | $2.74M 10-Q · filed 2022-11-14 |
| 2021-06-30 | $3.67M 10-Q · filed 2022-08-15 |
| 2021-03-31 | $4.05M 10-Q · filed 2022-05-13 |
| 2020-12-31 | $4.31M 10-K · filed 2023-03-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |